Advanced Oncotherapy (AVO) – Directorate Change
Advanced Oncotherapy plc (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that following the continued successful development of the Company’s first LIGHT system and the recent industrialisation agreement with Thales, the Board has decided to realign the roles and responsibilities of the Executive team to add additional focus to both operational […]
Advanced Oncotherapy (AVO) – Thales industrialisation agreement
Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has entered into an industrialisation agreement with Thales, for its proprietary LIGHT system. This agreement with Thales provides Advanced Oncotherapy with the support needed to move from the first LIGHT system, currently being developed for use at the Company’s flagship […]
Advanced Oncotherapy – Change of name of NOMAD & Joint Broker
Change of name of Nominated Adviser and Joint Broker The Company notifies that its Nominated Adviser and Joint Broker has changed its registered name from Westhouse Securities Limited to Stockdale Securities Limited. Advanced Oncotherapy Plc www.avoplc.com Sanjeev Pandya, CEO Tel: +44 20 3617 8728 Nicolas Serandour, CFO Stockdale Securities (Nomad & Joint Broker) Antonio […]
Alan Green discusses AVO, ADL and FDBK on the VOX Markets podcast
Alan Green discusses Advanced Oncotherapy (AVO), Andalas Energy & Power (ADL) and Feedback (FDBK) with Justin Waite on the VOX Markets podcast. The interview is 20 minutes 20 seconds in. Click here to listen.
Hardman & Co – Advanced Oncotherapy (AVO) – China- an emerging opportunity
Advanced Oncotherapy (AVO) – Focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN facility in Switzerland. Commercial momentum is building, having recently secured a second purchase order in China, formed a JV with Circle to operate potentially the first proton therapy facility […]
Live Charting with Zak Mir and Alan Green – TipTV
Live Charting with Zak Mir and Brand CEO Alan Green – TipTV. Discussing FTSE100, Nasdaq, Pantheon Resources (PANR), Optibiotix (OPTI), Advanced Oncotherapy (AVO) and other stocks.
Work Starts On First UK Proton Therapy Centre – Sky News
By Tom Platt, Sky News Reporter. The private clinic, due to open by the end of the year, means cancer patients can be treated in Britain rather than go abroad. Construction will begin today on the first UK clinic set to provide proton therapy. The private centre in Newport is expected to open by the […]
Advanced Oncotherapy to present at the Innovators & Investors Forum 2016
Advanced Oncotherapy to present at the Innovators & Investors Forum 2016. (From Stockmarket Wire) Nicolas Serandour, CFO of proton therapy systems developer Advanced Oncotherapy (AVO), [AVO] is to present at the Innovators & Investors Forum 2016 in London on Tuesday 2nd February 2016. The Innovators & Investors Forum is organised in partnership with Cenkos […]
Ashya King goes back to school full time
Published in The Guardian today. Parents of brain cancer survivor say they are proud of their son, who has recovered well after proton beam therapy in Prague. The father of brain cancer survivor Ashya King has said he is proud as his son returns to school full time. Brett King said six-year-old Ashya was doing very […]
Malcolm Stacey’s share tip of the year No 1 – buy Advanced Oncotherapy
Malcolm Stacey’s share tip of the year No 1 – buy Advanced Oncotherapy By Malcolm Stacey | Saturday 26 December 2015 Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I […]